Featured Research

from universities, journals, and other organizations

Seeing The New Millennium ... And Beyond

Date:
May 12, 1999
Source:
Michigan State University
Summary:
If Dr. Michael Fossel is right, most of us will not only live to see the start of the new millennium, but the year 2100 as well. Fossel, a clinical professor of medicine at Michigan State University, is convinced that sometime during this next millennium, biomedical research will make such incredible advances that people's lifespans could reach as high as 200 years.

If Dr. Michael Fossel is right, most of us will not only live to see the start of the new millennium, but the year 2100 as well.

Fossel, a clinical professor of medicine at Michigan State University, is convinced that sometime during this next millennium, biomedical research will make such incredible advances that people's lifespans could reach as high as 200 years.

Fossel, the editor of the Journal of Anti-Aging Medicine and author of Reversing Human Aging, says maladies such as cancer and heart disease will be conquered in the not-too-distant future.

"Doctors have known for years that as we age, our genes down-regulate, weaken and turn off our defense mechanisms, leaving us more vulnerable to disease," he says. "However, until now, doctors have known little about what the clock was and how it is directly responsible for the aging process."

The key, he says, lies in a tiny bit of molecular material called a telomere. Located at the tip of every chromosome, the telomere is our biological clock, the timekeeper that ticks inside each human cell, telling it when to get old.

As we age, most telemores shrink and eventually die, killing the cell. Learning to lengthen the telemores, essentially re-setting our biological clock, will have an impact on heart disease, Alzheimer's disease, and other illnesses.

Cancer, however, is a different beast. Because cancer cells tend to proliferate out of control, the key there is shortening the telemores.

Research in both areas is continuing. Fossel says he's optimistic that life-saving advances will be made before the end of the first decade of the 21st century.


Story Source:

The above story is based on materials provided by Michigan State University. Note: Materials may be edited for content and length.


Cite This Page:

Michigan State University. "Seeing The New Millennium ... And Beyond." ScienceDaily. ScienceDaily, 12 May 1999. <www.sciencedaily.com/releases/1999/05/990512075615.htm>.
Michigan State University. (1999, May 12). Seeing The New Millennium ... And Beyond. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1999/05/990512075615.htm
Michigan State University. "Seeing The New Millennium ... And Beyond." ScienceDaily. www.sciencedaily.com/releases/1999/05/990512075615.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins